Juha M Hiekkaranta, Mirella Ahonen, Elisa Mäkäräinen, Pasi Ohtonen, Juha Saarnio, Tero Rautio
{"title":"Ventralex™ ST 疝修补术治疗小脐带疝安全有效:回顾性队列研究","authors":"Juha M Hiekkaranta, Mirella Ahonen, Elisa Mäkäräinen, Pasi Ohtonen, Juha Saarnio, Tero Rautio","doi":"10.3389/jaws.2023.11499","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Hernia patches for umbilical hernia repair have gained popularity due to their short operation time and ease of use. However, up to 10% re-operation and 8% recurrence rates at 2-year follow-up have been published. This retrospective cohort study presents the long-term results of the hernia patch technique for umbilical hernia repair. <b>Methods:</b> All adult patients who underwent a primary umbilical hernia repair at Oulu University Hospital hernia surgery units during 2014-2018 were included in the study. The primary outcome measure was recurrence rate. Secondary outcomes were complications and re-operation rate. <b>Results:</b> A total of 619 elective primary umbilical hernia repairs were performed during 2014-2018. The major technique used was Ventralex™ ST hernia patch repair (79.0%, 488/619) for small hernias with a mean width of 1.8 (SD 0.79) cm. Most of the patches (84.7%, 414/488) were placed in the preperitoneal space. Hernia recurrence rate of patient operated on using Ventralex™ ST hernia patch was 2.5% (12/488) during a mean follow-up time of 68 (SD 16, 43-98) months. Re-operation rate for another reason than recurrence was 1.6% (8/488). Clavien-Dindo complications ≥3 occurred in 4.1% (20/488) of cases and surgical site infection rate was 3.3% (16/488). <b>Conclusion:</b> Umbilical hernia repair using a Ventralex™ ST hernia patch placed in preperitoneal space have acceptable results in terms of recurrence and re-operations in this cohort study.</p>","PeriodicalId":10587,"journal":{"name":"Coffee Science","volume":"11 1","pages":"11499"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831647/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ventralex™ ST Hernia Patch Repair for Small Umbilical Hernia is Safe and Effective: A Retrospective Cohort Study.\",\"authors\":\"Juha M Hiekkaranta, Mirella Ahonen, Elisa Mäkäräinen, Pasi Ohtonen, Juha Saarnio, Tero Rautio\",\"doi\":\"10.3389/jaws.2023.11499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Hernia patches for umbilical hernia repair have gained popularity due to their short operation time and ease of use. However, up to 10% re-operation and 8% recurrence rates at 2-year follow-up have been published. This retrospective cohort study presents the long-term results of the hernia patch technique for umbilical hernia repair. <b>Methods:</b> All adult patients who underwent a primary umbilical hernia repair at Oulu University Hospital hernia surgery units during 2014-2018 were included in the study. The primary outcome measure was recurrence rate. Secondary outcomes were complications and re-operation rate. <b>Results:</b> A total of 619 elective primary umbilical hernia repairs were performed during 2014-2018. The major technique used was Ventralex™ ST hernia patch repair (79.0%, 488/619) for small hernias with a mean width of 1.8 (SD 0.79) cm. Most of the patches (84.7%, 414/488) were placed in the preperitoneal space. Hernia recurrence rate of patient operated on using Ventralex™ ST hernia patch was 2.5% (12/488) during a mean follow-up time of 68 (SD 16, 43-98) months. Re-operation rate for another reason than recurrence was 1.6% (8/488). Clavien-Dindo complications ≥3 occurred in 4.1% (20/488) of cases and surgical site infection rate was 3.3% (16/488). <b>Conclusion:</b> Umbilical hernia repair using a Ventralex™ ST hernia patch placed in preperitoneal space have acceptable results in terms of recurrence and re-operations in this cohort study.</p>\",\"PeriodicalId\":10587,\"journal\":{\"name\":\"Coffee Science\",\"volume\":\"11 1\",\"pages\":\"11499\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831647/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Coffee Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/jaws.2023.11499\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Agricultural and Biological Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coffee Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/jaws.2023.11499","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 0
摘要
背景:用于脐疝修补的疝气补片因其手术时间短、使用方便而广受欢迎。然而,有报道称,再次手术率高达 10%,2 年随访复发率为 8%。这项回顾性队列研究介绍了疝气补片技术用于脐疝修补术的长期效果。研究方法研究纳入了2014-2018年间在奥卢大学医院疝外科接受初次脐疝修补术的所有成年患者。主要结果指标为复发率。次要结果为并发症和再次手术率。研究结果2014-2018年间共进行了619例择期原发性脐疝修补术。使用的主要技术是 Ventralex™ ST 疝补片修补术(79.0%,488/619),用于平均宽度为 1.8(SD 0.79)厘米的小疝。大多数补片(84.7%,414/488)被放置在腹膜前间隙。使用 Ventralex™ ST 疝气补片进行手术的患者在平均 68 个月(标准差 16,43-98)的随访期间,疝气复发率为 2.5%(12/488)。除复发外,因其他原因再次手术的比例为 1.6%(8/488)。克拉维恩-丁多并发症≥3的病例占 4.1%(20/488),手术部位感染率为 3.3%(16/488)。结论在这项队列研究中,使用放置在腹膜前间隙的 Ventralex™ ST 疝修补片进行脐疝修补术,在复发和再次手术方面取得了可接受的结果。
Ventralex™ ST Hernia Patch Repair for Small Umbilical Hernia is Safe and Effective: A Retrospective Cohort Study.
Background: Hernia patches for umbilical hernia repair have gained popularity due to their short operation time and ease of use. However, up to 10% re-operation and 8% recurrence rates at 2-year follow-up have been published. This retrospective cohort study presents the long-term results of the hernia patch technique for umbilical hernia repair. Methods: All adult patients who underwent a primary umbilical hernia repair at Oulu University Hospital hernia surgery units during 2014-2018 were included in the study. The primary outcome measure was recurrence rate. Secondary outcomes were complications and re-operation rate. Results: A total of 619 elective primary umbilical hernia repairs were performed during 2014-2018. The major technique used was Ventralex™ ST hernia patch repair (79.0%, 488/619) for small hernias with a mean width of 1.8 (SD 0.79) cm. Most of the patches (84.7%, 414/488) were placed in the preperitoneal space. Hernia recurrence rate of patient operated on using Ventralex™ ST hernia patch was 2.5% (12/488) during a mean follow-up time of 68 (SD 16, 43-98) months. Re-operation rate for another reason than recurrence was 1.6% (8/488). Clavien-Dindo complications ≥3 occurred in 4.1% (20/488) of cases and surgical site infection rate was 3.3% (16/488). Conclusion: Umbilical hernia repair using a Ventralex™ ST hernia patch placed in preperitoneal space have acceptable results in terms of recurrence and re-operations in this cohort study.